Literature DB >> 22840256

Allergy alerts in electronic health records for hospitalized patients.

Rebeca González-Gregori1, M Dolores Hernández Fernandez De Rojas, Ramón López-Salgueiro, Miguel Díaz-Palacios, Antonio Nieto García.   

Abstract

BACKGROUND: Electronic health records (EHRs) are used to register important health-related information, such as allergic conditions, and contribute to the safety and quality of medical care.
OBJECTIVES: To evaluate the use of allergy alert entries in EHRs and to establish the allergy profile of hospitalized patients.
METHODS: Allergy data recorded in EHRs were analyzed in a cross-sectional, observational, descriptive study of patients admitted to the hospital from January 1 through June 30, 2011.
RESULTS: A total of 15,534 patients were admitted to the hospital during the study period. The rate of inclusion of allergy information in the EHRs was 64.4%. In 2,106 patients an alert was activated to declare an allergy, intolerance, or any other type of adverse reaction. Drugs were the most common responsible agent (74.4%), followed by foods (12.6%) and materials (4.8%). Entries for drug allergy or intolerance were more common in females (64.8%) than males, with a significant statistical difference (P < .01), and increased proportionally with age. Entries for food allergy or intolerance were also more common in females (58.0%) than males (P < .01), but this trend was reversed in the 0- to 15-year-old age group. By contrast, the entries for food allergy or intolerance decreased proportionally with age. In 7,907 cases the EHRs revealed that patients were free of allergies, intolerances, or any other type of adverse reactions.
CONCLUSION: Drug allergy was the most frequently reported allergic condition, followed by foods and materials. Allergy alerts vary depending on age and sex. The proper use of a system for allergy alerts included in EHRs provides valuable information about hospitalized patients, contributing to the improvement of clinical practice.
Copyright © 2012 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22840256     DOI: 10.1016/j.anai.2012.06.006

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  7 in total

Review 1.  Update on Quinolone Allergy.

Authors:  Inmaculada Doña; Esther Moreno; Natalia Pérez-Sánchez; Inmaculada Andreu; Dolores Hernández Fernandez de Rojas; María José Torres
Journal:  Curr Allergy Asthma Rep       Date:  2017-08       Impact factor: 4.806

Review 2.  The Use of Electronic Health Records to Study Drug-Induced Hypersensitivity Reactions from 2000 to 2021: A Systematic Review.

Authors:  Fatima Bassir; Sheril Varghese; Liqin Wang; Yen Po Chin; Li Zhou
Journal:  Immunol Allergy Clin North Am       Date:  2022-03-31       Impact factor: 3.152

3.  Categorization of adverse drug reactions in electronic health records.

Authors:  Caroline Foreman; William B Smith; Gillian E Caughey; Sepehr Shakib
Journal:  Pharmacol Res Perspect       Date:  2020-04

4.  Clinical Decision Support Systems for Drug Allergy Checking: Systematic Review.

Authors:  Laura Légat; Sven Van Laere; Marc Nyssen; Stephane Steurbaut; Alain G Dupont; Pieter Cornu
Journal:  J Med Internet Res       Date:  2018-09-07       Impact factor: 5.428

Review 5.  Quinolone Allergy.

Authors:  Edoabasi U McGee; Essie Samuel; Bernadett Boronea; Nakoasha Dillard; Madison N Milby; Susan J Lewis
Journal:  Pharmacy (Basel)       Date:  2019-07-19

6.  Immediate Hypersensitivity to Fluoroquinolones: 
A Cohort Assessing Cross-Reactivity.

Authors:  Sara F Azimi; Vincent Mainella; Meghan N Jeffres
Journal:  Open Forum Infect Dis       Date:  2022-03-02       Impact factor: 3.835

7.  Impact of Clinical Decision Support on Time to Order Resolution for Patients with Documented Allergies.

Authors:  Tenielle Watkins; Sandra M Aguero; Michael Jaecks
Journal:  Pharmacy (Basel)       Date:  2018-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.